C20ORF20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.859400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.311200E-01
Normal-vs-Stage2
2.548600E-01
Normal-vs-Stage3
7.412800E-01
Normal-vs-Stage4
5.520800E-01
Stage1-vs-Stage2
7.159000E-01
Stage1-vs-Stage3
6.590200E-01
Stage1-vs-Stage4
4.565800E-01
Stage2-vs-Stage3
3.568600E-01
Stage2-vs-Stage4
2.799400E-01
Stage3-vs-Stage4
8.802200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.781100E-03
Normal-vs-AfricanAmerican
2.580400E-01
Normal-vs-Asian
5.580500E-02
Caucasian-vs-AfricanAmerican
8.217600E-01
Caucasian-vs-Asian
5.264400E-01
AfricanAmerican-vs-Asian
3.882800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.355200E-04
Normal-vs-Female
3.448400E-01
Male-vs-Female
1.510410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.971600E-01
Normal-vs-Age(41-60Yrs)
2.037600E-01
Normal-vs-Age(61-80Yrs)
3.374400E-01
Normal-vs-Age(81-100Yrs)
2.681700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.791400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.595400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.685800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.210800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.909800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.924390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.481700E-02
Normal-vs-Daily Drinker
1.277130E-03
Normal-vs-Weekly Drinker
1.892580E-01
Normal-vs-Occasional Drinker
2.138000E-01
Normal-vs-Social Drinker
3.647600E-01
Non Drinker-vs-Daily Drinker
1.945190E-01
Non Drinker-vs-Weekly Drinker
5.096400E-01
Non Drinker-vs-Occasional Drinker
4.683400E-01
Non Drinker-vs-Social Drinker
9.239800E-01
Daily Drinker-vs-Weekly Drinker
6.127000E-01
Daily Drinker-vs-Occasional Drinker
6.078000E-01
Daily Drinker-vs-Social Drinker
2.133400E-01
Weekly Drinker-vs-Occasional Drinker
9.837200E-01
Weekly Drinker-vs-Social Drinker
4.601200E-01
Occasional Drinker-vs-Social Drinker
4.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.949400E-01
Normal-vs-Grade 2
9.296800E-01
Normal-vs-Grade 3
9.847400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.579700E-03
Grade 1-vs-Grade 3
3.577400E-04
Grade 1-vs-Grade 4
7.949400E-01
Grade 2-vs-Grade 3
1.106180E-01
Grade 2-vs-Grade 4
9.296800E-01
Grade 3-vs-Grade 4
9.847400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.725000E-01
Normal-vs-NonDiabetic
5.803300E-04
Diabetic-vs-NonDiabetic
1.250790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.993900E-02
Normal-vs-NoPancreatitis
2.978000E-01
Pancreatitis-vs-NoPancreatitis
1.188620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.839670E-03
Normal-vs-N1
2.772400E-01
N0-vs-N1
9.409400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.9680000052964E-08
Normal-vs-TP53-NonMutant
4.608400E-02
TP53-Mutant-vs-TP53-NonMutant
5.45230000037478E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
